In addition, because GLP-1 inhibits the AGEs-induced RAGE gene expression and ROS generation in T2D [158], it may be hypothesized that semaglutide could reduce ROS production through AGE-RAGE mediation [159]. This evidence concerns the gene GCG and type 2 diabetes mellitus.